Results showed that the ingredient significantly increased NAD+ levels in senescent fibroblasts, activated the SIRT1 signaling pathway, reduced the expression of senescence-associated -galactosidase (SA--gal), decreased intracellular reactive oxygen species accumulation, and promoted collagen synthesis
The most common side effect is simply pain at the injection site
Published human trials mainly studied oral and intravenous forms, so subcutaneous amounts come from community practice rather than an approved clinical protocol
They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
Baseline Assessment: Before initiating treatment, comprehensive medical evaluation should identify any contraindications or conditions requiring special monitoring